Ajooni Biotech (NSE:AJOONI) ROCE % : 9.04% (As of Mar. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Ajooni Biotech ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Ajooni Biotech's annualized ROCE % for the quarter that ended in Mar. 2023 was 9.04%.

Ajooni Biotech ROCE % Historical Data

The historical data trend for Ajooni Biotech's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ajooni Biotech ROCE % Chart

Ajooni Biotech Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

ROCE %

Get a 7-Day Free Trial

3.96

4.74

5.74

10.96

6.55

Ajooni Biotech Quarterly Data
	Mar15	Mar16	Mar17	Aug17	Mar18	Sep18	Mar19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
ROCE %	Get a 7-Day Free Trial															3.13	11.09	7.12	3.07	9.04

Ajooni Biotech ROCE % Calculation

Ajooni Biotech's annualized ROCE % for the fiscal year that ended in Mar. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	20.454	/	( ( (290.175 - 100.587)	+	(587.314 - 152.095) )	/ 2 )
	=	20.454	/	( (189.588	+	435.219)	/ 2 )
	=	20.454	/	312.4035
	=	6.55 %

Ajooni Biotech's ROCE % of for the quarter that ended in Mar. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2023 )		(Q: Dec. 2022 )		(Q: Mar. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2023 )		(Q: Dec. 2022 )		(Q: Mar. 2023 )
	=	38.28	/	( ( (536.918 - 125.439)	+	(587.314 - 152.095) )	/ 2 )
	=	38.28	/	( ( 411.479	+	435.219 )	/ 2 )
	=	38.28	/	423.349
	=	9.04 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2023) EBIT data.

Ajooni Biotech (NSE:AJOONI) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Ajooni Biotech ROCE % Related Terms

Thank you for viewing the detailed overview of Ajooni Biotech's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ajooni Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Ajooni Biotech Ltd (NSE:AJOONI) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

D-118, Industrial Area, Phase VII, Mohali, PB, IND, 160055

Website

https://www.ajoonibiotech.com

Ajooni Biotech Ltd is engaged in the production of animal feed. The company's products of cattle feed include Nurture Calf Starter, Winner 10ltr, Hiffer/Grower, Energy Plus, Eco- 5ltr, Milk Booster, & Buff Power, and its feed supplements include Autovita, Livtus, Caltus, Rumitus, and other products. It derives majority portion of the revenue from the manufacturing of cattle feed. The company operates only in India.

Ajooni Biotech Headlines

No Headlines